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Apart from the bacteria that were found in culture (n=63) in the 24 positive samples, a total of 273 the abundance of P. acnes in samples was negatively correlated to their total DNA concentration 1 sample (Supplementary Figure 5 ), supporting that P. acnes was a contaminant in this study [25, 26] .
2 For other species, such correlation could not be tested because of their low occurrence in samples.
3
We identified 66 likely contaminants (Figure 3 , Supplementary Table 2 ), some being commonly found 4 in culture (such as Micrococcus luteus) or as reagents contaminants [27] . Others were unexpected 5 such as Borrelia sp. (samples 103, 104, 108 and 110) or Rickettsia japonica (sample 117). Still, the 6 taxonomic assignment of the contigs did not confirm the presence of those species and manual blastn 7 of reads against the NCBI nr database supported that they were likely in silico contaminants (data not 8 shown) [27, 28] . Besides, we identified 25 species that could be due to a misclassification of reads to 9 closely related bacteria, such as in samples 184 (where Corynebacterium striatum was found in 10 culture, and some metagenomic reads were identified as Dermabacter sp. and Corynebacterium 11 pyruviciproducens), samples from patient C (19, 103, 104 where Acinetobacter baumannii and 12 Achromobacter xylosoxidans were found in culture, and some reads were identified as from other 13 Acinetobacter spp., Achromobacter spp., or Advenella kashmirensis, a bacterium close to 14 Achromobacter) ( Supplementary Table 2 ). Hence, a total of 182 bacteria not recovered in culture and 15 not acknowledged as contaminants were identified in metagenomic sequencing. For one sample that 16 was monomicrobial in culture (sample 46, that yielded S. anginosus), 38 other species were identified 17 by metagenomics. Interestingly, these species appeared to be commonly found in the oropharyngeal 18 microbiota, which was consistent with the site of the infection (mandible). In polymicrobial samples 19 such as samples 4 and 140 (patient B), 90 and 158 (patient H), 108 and 181 (patient I), metagenomic 20 sequencing identified several more anaerobic bacteria (range 3-40, see Supplementary Table 2 , in 21 consistence with the sporadic isolation of such bacteria in the routine culture of these of samples. In
22
both samples 4 and 140 from patient B, the most abundant species was Propionibacterium 23 propionicum (respective abundances of 71.5% and 43.2%) that was not found in culture. Arguments 24 in contradiction with P. propionicum being a contaminant in these samples are that the species found 25 in other samples was P. acnes, and that the abundance of P. propionicum was high (supplementary because some bacteria and ARDs were found in sequencing but not in culture. Of note, the prediction 1 of susceptibility to fluoroquinolones was correct in 100% (24/24) samples 2 3 Influence of downsizing the samples to 1M reads 4 We ran the same pipeline analysis onto the 24 samples downsized at 1M reads. We observed that 5 the taxonomic distribution did not apparently change for the most abundant species (Supplementary 6 Figure 9 ), but the mean genome coverage of the main pathogen was lower in the downsized group 7 than in the full-reads group (3.9% vs. 8.9%, Student paired test p<0.001, Supplementary Figure 10 ).
8
Also, only 86 ARDs were found after downsizing while 151 were detected before (Student paired test 9 p<0.001, Supplementary Figure 9 ). Of note, the impact of downsizing was observed in both 1 First, we could only sequence 24 out of 179 samples, due to a low amount of bacterial DNA that could 2 be recovered from the samples. This is the main limitation of this study as it reduced the diversity of 3 clinical situations that we could address. Nonetheless, the samples from this study have been frozen 4 and thawed, which decays bacteria and releases DNA. As the DNA extraction method we used 5 eliminates free DNA after lysing eukaryotic cells, it is likely that we could have sequenced more 6 samples if they would not have been frozen. This said, recovering enough bacterial DNA (in terms of 7 quantity and proportion with respect to human DNA) remains challenging. Also, the high cost of NGS 8 currently prevents its routine application. We tested the impact of a lower depth of sequencing and 9 showed that despite the taxonomic profiles of the bacterial populations were similar, the inference of 10 antibiotic susceptibility was less accurate due to a lower recovery of genes involved in antibiotic 11 resistance. Our results suggest that clinical metagenomics should indeed benefit from the highest 12 depth of sequencing. Another limitation of the study is that we did not concomitantly sequence a 13 negative control to identify the putative contaminants that would originate from the sample process. 
18
Besides, our observations suggest that clinical metagenomics will soon require, as for clinical 19 microbiology, a specific expertise combining clinical, biological and bioinformatic skills in order to infer 20 clinically relevant results from metagenomic data. In this perspective, the development of clinical 21 metagenomics will need the definition of quality standards, e.g. what is the sufficient genome 22 coverage for a given bacterium to consider that its antibiotic susceptibility profile can be likely inferred.
23
In the long term, algorithms should be built to provide clinicians with clear data and robust algorithms 24 to support clinical decisions.
25
In conclusion, we showed that metagenomic sequencing of BJI samples was a potential tool to 26 support conventional methods. In this perspective, its main limitations (DNA extraction, cost and data 27 management) should be tackled, and the clinical benefit provided by clinical metagenomics should 28 now be assessed in a prospective fashion. 
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